BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 15274159)

  • 21. Transradial left main stem rotational artherectomy and stenting: case report and literature review.
    Prasad SB; Malaiapan Y; Ahmar W; Meredith IT
    Cardiovasc Revasc Med; 2009; 10(2):136-9. PubMed ID: 19327679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approaches to ostial and bifurcation lesions.
    Hoye A; van der Giessen WJ
    J Interv Cardiol; 2004 Dec; 17(6):397-403. PubMed ID: 15546292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotational atherectomy: a "survivor" in the drug-eluting stent era.
    Zimarino M; Corcos T; Bramucci E; Tamburino C
    Cardiovasc Revasc Med; 2012; 13(3):185-92. PubMed ID: 22522057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous transluminal rotational atherectomy for coronary artery disease.
    Wasiak J; Law J; Watson P; Spinks A
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003334. PubMed ID: 23235596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Debulking for in-stent restenosis in the brachytherapy era: does it still have a role?
    Tuli A; Subramaniyam V; Bakir S; Block PC; Crocker IR
    J Invasive Cardiol; 2003 Apr; 15(4):209-12. PubMed ID: 12668849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous rotational coronary atherectomy: initial Green Lane and Mercy hospitals' experience.
    Porter GF; Ormiston JA; Webster MW
    N Z Med J; 1996 Jun; 109(1023):203-5. PubMed ID: 8668298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions.
    Fernandez JP; Hobson AR; McKenzie D; Shah N; Sinha MK; Wells TA; Levy TM; Swallow RA; Talwar S; O'Kane PD
    EuroIntervention; 2013 Jun; 9(2):243-50. PubMed ID: 23454891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherectomy for infrainguinal peripheral artery disease.
    Garcia LA; Lyden SP
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II105-15. PubMed ID: 19624078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of transluminal mechanical coronary recanalization].
    Sheiban I; Tonni S; Gorni R; Trevi G
    Cardiologia; 1994 Dec; 39(12 Suppl 1):39-46. PubMed ID: 7634302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [15 years of coronary angioplasty: focus on the different techniques].
    Dupouy P; Belarbi A; el Ghalid A; Aptecar E; Teiger E; Dubois-Rande JL
    Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):433-7. PubMed ID: 8669794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on PTCA: what are its limitations? Can they be overcome by new devices? A look at atherectomy, intra-arterial stents, and laser catheters.
    Feldman T; Moscucci M
    J Crit Illn; 1993 Apr; 8(4):461-78. PubMed ID: 10148463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The place of directional coronary atherectomy for the treatment of in-stent restenosis.
    Palacios IF; Sanchez PL; Mahdi NA
    Semin Interv Cardiol; 2000 Dec; 5(4):209-16. PubMed ID: 11244518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of calcified ostial disease by rotational atherectomy and adjunctive cutting balloon angioplasty prior to stent implantation.
    Palmer ND; Nair RK; Ramsdale DR
    Int J Cardiovasc Intervent; 2004; 6(3-4):134-6. PubMed ID: 16146906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The draw-back stent deployment technique: a strategy for the treatment of coronary branch ostial lesions.
    Schwartz L; Morsi A
    J Invasive Cardiol; 2002 Feb; 14(2):66-71. PubMed ID: 11818640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease.
    Di Sciascio G; Patti G
    Cardiologia; 1999 Apr; 44(4):333-9. PubMed ID: 10371784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evidence-based approach to the use of rotational and directional coronary atherectomy in the era of drug-eluting stents: when does it make sense?
    Tran T; Brown M; Lasala J
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):650-62. PubMed ID: 18942126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
    J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study.
    Ribichini F; Ferrero V; Rognoni A; Marino P; Brunelleschi S; Vassanelli C
    J Interv Cardiol; 2007 Apr; 20(2):114-21. PubMed ID: 17391219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotational atherectomy with drug-eluting stents: a necessary technique in the current era.
    Lozano I; Rondan J; Avanzas P
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):160; author reply 161. PubMed ID: 21069801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.